Jubilant Pharmova share news, announcements and annual reports
NSE: JUBLPHARMABSE: 530019Pharmaceuticals & BiotechnologySmall Cap
Jubilant Pharmova Limited · Formerly Jubilant Life Sciences · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 1981 on BSE, Jun 2003 on NSE
Last close ₹959.80up ₹22.80 (2.43%)BSE ₹955.75
Share price at the NSE close on 27 Oct 2026. Previous close ₹937.00.
27 Oct: open ₹939.80, high ₹965.90, low ₹931.40
52-week range of traded prices to 27 Oct 2026
₹786.05Low, 9 Mar 2026₹1,183.00High, 4 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹15,288 Cr422nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 43.42
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹59 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 37.17
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.16
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.52%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 5.3%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹59 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 6.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.45
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,43,47353.0% delivered
Jubilant Pharmova has 1,151 announcements on record, routine notices left out; 6 in the 30 days to 28 Oct 2026, the latest on 21 Oct 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Jubilant Pharmova quarterly results
Aug10Mon
The board met on 10 Aug 2026 to consider financial results
Notice filed 5 Aug 2026
Jubilant Pharmova annual reports, presentations and earnings calls
The company's own documents, latest first.Jubilant Pharmova financials, year by year
Annual reports17
- Annual report, year to Mar 20261 Aug 2026
- Annual report, year to Mar 20255 Aug 2025
- Annual report, year to Mar 20248 Aug 2024
- Annual report, year to Mar 20238 Aug 2023, a zip file
- Annual report, year to Mar 20223 Sep 2022, a zip file
12 earlier reports
- Annual report, year to Mar 202130 Aug 2021, a zip file
- Annual report, year to Mar 202019 Aug 2020, a zip file
- Annual report, year to Mar 201931 Aug 2019, a zip file
- Annual report, year to Mar 201827 Sep 2018, a zip file
- Annual report, year to Mar 201711 Sep 2017, a zip file
- Annual report, year to Mar 20161 Sep 2016, a zip file
- Annual report, year to Mar 20157 Aug 2015, a zip file
- Annual report, year to Mar 20147 Aug 2014, a zip file
- Annual report, year to Mar 201320 Aug 2013, a zip file
- Annual report, year to Mar 201225 Sep 2012, a zip file
- Annual report, year to Mar 20119 Sep 2011, a zip file
- Annual report, year to Mar 201013 Apr 2011, a zip file
Investor presentations3
- Investor Presentation24 Feb 2025
- Investor Presentation18 Jun 2021
- Earning Presentation of the Company held on October 28, 2014.28 Oct 2014, a zip file
Earnings calls12
- Transcript27 May 2026
- Link of Recording22 May 2026
- Transcript4 Mar 2025
- General Updates Audio Recording of Investor Meet24 Feb 2025
- Transcript9 Feb 2023
7 earlier call documents
- Link of Recording3 Feb 2023
- Transcript of Analysts/Institutional Investor Meet/Con. Call31 Oct 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call22 Oct 2022
- We enclose the transcript of Analyst and Investor Conference Call for Unaudited financial results for the quarter ended June 30, 2022 conducted after the meeting of Board of Directors held on Tuesday, August 2, 2022This is for your information and records.8 Aug 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call2 Aug 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call2 Jun 2022
- Audio Call Recording of Analysts/Institutional Investor Meet/Con. Call28 May 2022
Jubilant Pharmova merger and demerger filings
Filings about a merger, demerger or scheme of arrangement, latest first.
Filings6
- Scheme of Arrangement - Outcome of NCLT Convened Meetings15 Jan 2022
- Scheme of Arrangement - Notice to Unsecured Creditors10 Dec 2021
- Scheme of Arrangement - Notice to the Equity Shareholders10 Dec 2021
- Scheme of Arrangement23 Jul 2021
- Jubilant Life Sciences Limited has informed that pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the disclosure pertaining to approval of the Composite Scheme of Arrangement by the Board of Directors of the Company at its meeting held on October 25, 2019.25 Oct 2019
Jubilant Pharmova share news and announcements
Newest first. Page 1 of 24.
Oct 2026
21 Oct · Meeting
21 Oct · Rating
14 Oct · Rating
8 Oct
Sep 2026
28 Sep
11 Sep
1 Sep · General Updates
Aug 2026
28 Aug
23 Aug · General Updates
10 Aug · Results
5 Aug · Analysts
Jul 2026
30 Jul · Board meeting
Not held on this date
29 Jul · General Updates
19 Jul · General Updates
18 Jul · Meeting
16 Jul
16 Jul
Jun 2026
30 Jun
26 Jun
24 Jun
19 Jun
May 2026
29 May · General Updates
22 May · Analysts
22 May · Management
22 May · Business
22 May · Board meeting
22 May · Board meeting
22 May · Results
21 May · Analysts
18 May · Analysts
Apr 2026
24 Apr · Analysts
24 Apr · Analysts
Mar 2026
How the price met the news
The latest 30. The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 22 Oct 2026Credit ratingup 0.30%+0.9 pts vs Nifty 500market median 0.0% · volume 0.3× usual · delivery −6.1 pts against usual · The announcement
- 15 Oct 2026Credit ratingdown 0.07%−0.7 pts vs Nifty 500market median 0.0% · five sessions −0.7% (+0.8 pts vs Nifty 500) · volume 0.6× usual · delivery −3.8 pts against usual · The announcement
- 11 Aug 2026Resultsup 0.24%+0.5 pts vs Nifty 500market median −0.7% · five sessions −9.9% (−9.2 pts vs Nifty 500) · volume 5.5× usual · delivery −18.2 pts against usual · The announcement
- 25 May 2026Board or managers changedup 0.09%−1.1 pts vs Nifty 500market median 0.0% · five sessions −1.9% (−0.9 pts vs Nifty 500) · volume 2.7× usual · delivery −20.4 pts against usual · The announcement
- 22 May 2026Resultsdown 0.52%−0.7 pts vs Nifty 500market median −0.7% · five sessions −1.6% (−1.9 pts vs Nifty 500) · volume 4.3× usual · delivery −35.8 pts against usual · The announcement
- 6 Feb 2026Resultsdown 3.72%−3.8 pts vs Nifty 500market median −0.7% · five sessions −3.1% (−4.2 pts vs Nifty 500) · volume 3.2× usual · delivery −30.2 pts against usual · The announcement
- 31 Oct 2025Resultsdown 1.56%−1.0 pts vs Nifty 500market median −0.7% · five sessions +0.8% (+2.1 pts vs Nifty 500) · volume 3.8× usual · delivery −16.6 pts against usual · The announcement
- 1 Sep 2025Board or managers changedup 1.78%+0.7 pts vs Nifty 500market median 0.0% · five sessions +4.6% (+3.0 pts vs Nifty 500) · volume 0.4× usual · delivery −13.2 pts against usual · The announcement
- 29 Jul 2025Resultsdown 1.81%−2.5 pts vs Nifty 500market median −0.7% · five sessions −2.3% (−2.4 pts vs Nifty 500) · volume 3.9× usual · delivery −30.3 pts against usual · The announcement
- 16 May 2025Resultsup 4.42%+4.1 pts vs Nifty 500market median −0.7% · five sessions +18.1% (+18.9 pts vs Nifty 500) · volume 7.5× usual · delivery −9.5 pts against usual · The announcement
20 earlier announcements
- 16 May 2025Dividendup 4.42%+4.1 pts vs Nifty 500market median 0.0% · five sessions +18.1% (+18.9 pts vs Nifty 500) · volume 7.5× usual · delivery −9.5 pts against usual · The announcement
- 7 May 2025Credit ratingup 1.09%+0.6 pts vs Nifty 500market median 0.0% · five sessions +4.0% (+2.2 pts vs Nifty 500) · volume 0.2× usual · delivery −0.9 pts against usual · The announcement
- 31 Jan 2025Resultsup 1.75%+0.4 pts vs Nifty 500market median −0.7% · five sessions +10.2% (+8.0 pts vs Nifty 500) · volume 2.9× usual · delivery −30.2 pts against usual · The announcement
- 11 Dec 2024Credit ratingup 0.72%+0.5 pts vs Nifty 500market median 0.0% · five sessions −4.3% (−3.4 pts vs Nifty 500) · volume 0.6× usual · delivery +7.5 pts against usual · The announcement
- 25 Oct 2024Resultsdown 4.49%−3.2 pts vs Nifty 500market median −0.7% · five sessions +9.4% (+9.8 pts vs Nifty 500) · volume 2.4× usual · delivery −14.2 pts against usual · The announcement
- 5 Aug 2024Board or managers changeddown 0.83%+2.3 pts vs Nifty 500market median 0.0% · five sessions +1.1% (+2.6 pts vs Nifty 500) · volume 0.9× usual · delivery −11.5 pts against usual · The announcement
- 19 Jul 2024Resultsup 3.10%+4.6 pts vs Nifty 500market median −0.7% · five sessions +0.6% (+1.9 pts vs Nifty 500) · volume 19.5× usual · delivery −38.2 pts against usual · The announcement
- 29 May 2024Dividendup 0.41%+1.0 pts vs Nifty 500market median 0.0% · five sessions −8.9% (−3.9 pts vs Nifty 500) · volume 2.0× usual · delivery −24.0 pts against usual · The announcement
- 26 Mar 2024Credit ratingup 0.38%+0.3 pts vs Nifty 500market median 0.0% · five sessions +4.4% (+1.5 pts vs Nifty 500) · volume 0.3× usual · delivery +12.1 pts against usual · The announcement
- 26 Mar 2024Board or managers changedup 0.38%+0.3 pts vs Nifty 500market median 0.0% · five sessions +4.4% (+1.5 pts vs Nifty 500) · volume 0.3× usual · delivery +12.1 pts against usual · The announcement
- 2 Feb 2024Board or managers changedup 2.71%+2.0 pts vs Nifty 500market median 0.0% · five sessions −1.1% (−2.1 pts vs Nifty 500) · volume 9.6× usual · delivery −22.4 pts against usual · The announcement
- 2 Feb 2024Resultsup 2.71%+2.0 pts vs Nifty 500market median −0.7% · five sessions −1.1% (−2.1 pts vs Nifty 500) · volume 9.6× usual · delivery −22.4 pts against usual · The announcement
- 1 Sep 2023Board or managers changedup 0.28%−0.6 pts vs Nifty 500market median 0.0% · five sessions −1.0% (−3.7 pts vs Nifty 500) · volume 0.7× usual · delivery −4.5 pts against usual · The announcement
- 30 May 2023Dividenddown 7.29%−7.5 pts vs Nifty 500market median 0.0% · five sessions −5.7% (−6.3 pts vs Nifty 500) · volume 3.8× usual · delivery −20.1 pts against usual · The announcement
- 30 May 2023Board or managers changeddown 7.29%−7.5 pts vs Nifty 500market median 0.0% · five sessions −5.7% (−6.3 pts vs Nifty 500) · volume 3.8× usual · delivery −20.1 pts against usual · The announcement
- 6 Feb 2023Board or managers changeddown 3.51%−3.3 pts vs Nifty 500market median 0.0% · five sessions −5.9% (−6.3 pts vs Nifty 500) · volume 1.4× usual · delivery +3.2 pts against usual · The announcement
- 27 Dec 2022Credit ratingdown 1.25%−2.0 pts vs Nifty 500market median 0.0% · five sessions −4.4% (−5.9 pts vs Nifty 500) · volume 0.5× usual · delivery −2.2 pts against usual · The announcement
- 2 Aug 2022Resultsdown 2.89%−3.1 pts vs Nifty 500market median −0.7% · five sessions −6.5% (−7.5 pts vs Nifty 500) · volume 5.7× usual · delivery −26.2 pts against usual · The announcement
- 1 Jul 2022Board or managers changeddown 1.44%−1.5 pts vs Nifty 500market median 0.0% · five sessions +7.0% (+4.1 pts vs Nifty 500) · volume 1.0× usual · delivery −20.1 pts against usual · The announcement
- 30 May 2022Resultsup 0.61%−1.4 pts vs Nifty 500market median −0.7% · five sessions −3.0% (−4.4 pts vs Nifty 500) · volume 1.2× usual · delivery −2.8 pts against usual · The announcement
Jubilant Pharmova results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Revenue from operations | Quarter to Jun 2022 | Consolidated | 1,440.47 | 1,451.72 | +0.8% | 2 Aug 2022 | 24 Oct 2022 |
| Other income | Quarter to Jun 2022 | Consolidated | 22.56 | 11.31 | −49.9% | 2 Aug 2022 | 24 Oct 2022 |
| Revenue from operations | Quarter to Jun 2022 | Standalone | 200.04 | 204.57 | +2.3% | 2 Aug 2022 | 24 Oct 2022 |
| Other income | Quarter to Jun 2022 | Standalone | 14.77 | 10.24 | −30.7% | 2 Aug 2022 | 24 Oct 2022 |